Health
Weighing risks and benefits of COVID-19 vaccination in children – Medical Xpress
The U.S. Food and Drug Administration has approved Pfizer’s COVID-19 vaccine for use in children ages five to 11. Pfizer’s clinical…
The U.S. Food and Drug Administration has approved Pfizer’s COVID-19 vaccine for use in children ages five to 11. Pfizer’s clinical trial results indicate the vaccine is safe and effective in this age group.
This is an important development. COVID-19 infectionsare…
Continue Reading
-
Noosa News19 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
General24 hours agoIranian supreme leader makes first public appearance since war with Israel
-
Noosa News24 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years
-
General21 hours agoEV buses join Perth’s wider suburban network, ‘milestone’ for diesel phase-out